Leading Life Sciences Company Enhances Compliance with Analytics & Automation Software

Lextegrity’s Integrity Gateway Approvals & Disclosures and Compliance Monitoring applications were chosen in an ongoing DOJ and SEC FCPA investigation by a leading global biopharmaceutical company.

A leading global life sciences company sought to enhance compliance controls and processes amid an ongoing FCPA investigation. Lextegrity’s Integrity Gateway Approvals & Disclosures and Integrity Gateway Compliance Monitoring applications were implemented quickly without the need for data scientists and engineers globally and in multiple languages. Compliance analytics and automation enhancements were implemented to bolster third-party risk management as well as monitor sponsorships and donations and benefits to government officials and healthcare professionals.

This case study will address:

• The high-risk areas this leading biopharmaceutical company needed to address
• The solution Lextegrity provided
• The successful implementation of the Integrity Gateway application

Read the case study today and see how Lextegrity helped a leading life sciences company effectively address high-risk areas amid an ongoing FCPA investigation.